GORDON CAMERON Biotech Baron
As an investment banker, Cameron, 37, managed a $50 million IPO for Acambis, a London vaccine producer. As its CFO, he helped Acambis win a $430 million contract from the U.S. to supply smallpox vaccine, a contract that transformed the company from a small R.-and-D. shop into a drugmaker with clout. So it's no wonder that the Acambis board took a chance on Cameron and named him CEO. The Scotsman, whose hobbies include golf, will try to tee up the first West Nile--virus vaccine in his first months on the job.
MARY WINSTON Prime Publisher
...
To continue reading:
or
Log-In
